Related Experiment Videos
Drug- and toxin-associated seizures
Brandon Wills1, Timothy Erickson
1Department of Emergency Medicine, University of Illinois, Chicago, Chicago, IL 60612, USA. bkwills@gmail.com
The Medical Clinics of North America
|October 18, 2005
Summary
Drug- and toxin-associated seizures (DTS) are common and often managed with supportive care. A detailed patient history is crucial for diagnosis and treatment, with specific interventions reserved for certain agents.
Area of Science:
- Toxicology
- Emergency Medicine
- Neurology
Background:
- Drug- and toxin-associated seizures (DTS) represent a significant clinical challenge.
- A diverse range of agents can precipitate seizures, complicating diagnosis and management.
Purpose of the Study:
- To review the etiology, diagnosis, and management of drug- and toxin-associated seizures.
- To emphasize the importance of clinical history in identifying causative agents.
Main Methods:
- Literature review of drug- and toxin-induced seizures.
- Analysis of diagnostic approaches and treatment strategies.
Main Results:
- Comprehensive patient history is paramount for identifying exposure agents.
- Most DTS cases respond to supportive care, primarily benzodiazepines.
- Specific antidotes or interventions are necessary for certain toxins and drugs.
Conclusions:
- Prompt recognition of DTS and thorough history taking are critical.
- Supportive care is the mainstay of treatment, but specific antidotes must be considered.
- Effective management hinges on identifying the causative agent and tailoring treatment accordingly.